We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+26.51%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$2.28B
AUM Growth
+$663M
Cap. Flow
+$192M
Cap. Flow %
8.42%
Top 10 Hldgs %
37.08%
Holding
98
New
19
Increased
31
Reduced
23
Closed
19

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$56.8M
2
BIIB icon
Biogen
BIIB
+$47.5M
3
UNH icon
UnitedHealth
UNH
+$32.1M
4
LNTH icon
Lantheus
LNTH
+$30.4M
5
AZO icon
AutoZone
AZO
+$29.5M

Top Sells

Rank Stock Value
1
VXRT
Vaxart
VXRT
+$72M
2
DECK icon
Deckers Outdoor
DECK
+$30.5M
3
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$29.6M
4
AMZN icon
Amazon
AMZN
+$25.4M
5
DLTR icon
Dollar Tree
DLTR
+$22.4M

Sector Composition

Rank Sector Weight
1 Healthcare 45.31%
2 Consumer Discretionary 15.79%
3 Consumer Staples 9.9%
4 Technology 5.31%
5 Industrials 3.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NERV icon
76
Minerva Neurosciences
NERV
$193M
$1.08M 0.05%
37,500
– –
XYLO
77
DELISTED
Xylo Technologies
XYLO
$962K 0.04%
32,143
– –
RIGL icon
78
Rigel Pharmaceuticals
RIGL
$698M
$957K 0.04%
+52,270
New +$940K
AGPU
79
Axe Compute Inc
AGPU
$98.1M
$795K 0.03%
1,615
+748
+86% +$349K
ADUS icon
80
Addus HomeCare
ADUS
$2.07B
– –
-52,000
Closed -$3.52M
BBWI icon
81
Bath & Body Works
BBWI
$4.22B
– –
-324,235
Closed -$3.03M
BWXT icon
82
BWX Technologies
BWXT
$15.8B
– –
-100,000
Closed -$4.87M
CAPR icon
83
Capricor Therapeutics
CAPR
$251M
– –
-268,630
Closed -$322K
DECK icon
84
Deckers Outdoor
DECK
$13.7B
– –
-1,365,108
Closed -$30.5M
DLTR icon
85
Dollar Tree
DLTR
$24.5B
– –
-305,183
Closed -$22.4M
EPC icon
86
CALL
Edgewell Personal Care
EPC
$1.28B
– –
-5,000
Closed -$12M
HSDT icon
87
Solana Company
HSDT
$97.5M
– –
-1
Closed -$607K
KMB icon
88
Kimberly-Clark
KMB
$36.1B
– –
-88,000
Closed -$11.3M
NNBR icon
89
NN Inc
NNBR
$286M
– –
-500,000
Closed -$865K
OTLK icon
90
Outlook Therapeutics
OTLK
$161M
– –
-70,619
Closed -$849K
PFE icon
91
Pfizer
PFE
$142B
– –
-714,612
Closed -$22.1M
TENX icon
92
Tenax Therapeutics
TENX
$524M
– –
-113
Closed -$104K
TGT icon
93
Target
TGT
$67.1B
– –
-180,000
Closed -$16.7M
TGTX icon
94
TG Therapeutics
TGTX
$7.06B
– –
-768,000
Closed -$7.56M
V icon
95
Visa
V
$682B
– –
-87,000
Closed -$14M
PGNX
96
DELISTED
Progenics Pharmaceuticals Inc
PGNX
– –
-350,000
Closed -$1.33M
NTGN
97
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
– –
-1,050,000
Closed -$2.77M
ATVI
98
DELISTED
Activision Blizzard
ATVI
– –
-136,000
Closed -$8.09M
1 2 3
4

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Armistice Capital held 98 positions worth $2.28B, up 41% from $1.62B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Armistice Capital deployed $192M of net new capital in Q2 2020, opening 19 new positions and adding to 31 existing holdings. Its largest new stake was Medtronic: 592,000 shares worth $54.3M.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 47% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Vaxart, an estimated $72M trimmed.

  • Armistice Capital's largest Q2 2020 buy was Medtronic: 592,000 shares worth $54.3M.
  • Armistice Capital added most to Biogen in Q2 2020, an estimated $47.5M increase.
  • Armistice Capital's biggest Q2 2020 reduction was Vaxart, cutting an estimated $72M.
  • Armistice Capital fully exited Deckers Outdoor in Q2 2020, selling an estimated $30.5M.
  • Armistice Capital's ten largest holdings make up 37% of its $2.28B portfolio in Q2 2020.
  • Armistice Capital opened 19 new positions and closed 19 in Q2 2020.
  • Armistice Capital's portfolio value rose 41% quarter-over-quarter to $2.28B.

Based on Armistice Capital's 13F filing for Q2 2020, filed 14 Aug 2020.